Correlation Between XBiotech and Cue Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XBiotech and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XBiotech and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XBiotech and Cue Biopharma, you can compare the effects of market volatilities on XBiotech and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XBiotech with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of XBiotech and Cue Biopharma.

Diversification Opportunities for XBiotech and Cue Biopharma

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between XBiotech and Cue is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding XBiotech and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and XBiotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XBiotech are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of XBiotech i.e., XBiotech and Cue Biopharma go up and down completely randomly.

Pair Corralation between XBiotech and Cue Biopharma

Given the investment horizon of 90 days XBiotech is expected to generate 0.62 times more return on investment than Cue Biopharma. However, XBiotech is 1.61 times less risky than Cue Biopharma. It trades about 0.07 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.01 per unit of risk. If you would invest  418.00  in XBiotech on September 2, 2024 and sell it today you would earn a total of  343.00  from holding XBiotech or generate 82.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

XBiotech  vs.  Cue Biopharma

 Performance 
       Timeline  
XBiotech 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in XBiotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak forward indicators, XBiotech unveiled solid returns over the last few months and may actually be approaching a breakup point.
Cue Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

XBiotech and Cue Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XBiotech and Cue Biopharma

The main advantage of trading using opposite XBiotech and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XBiotech position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.
The idea behind XBiotech and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk